Navigation Links
AGA Research Foundation Announces Endowment Gift from Takeda Pharmaceuticals U.S.A., Inc. to Support Gastroenterology Research
Date:5/14/2013

BETHESDA, Md., May 13, 2013 /PRNewswire-USNewswire/ -- Today, the American Gastroenterological Association announced that Takeda Pharmaceuticals U.S.A., Inc. will provide a $1.5 million unrestricted grant to the AGA Research Foundation endowment.  This grant to the AGA Research Foundation endowment funds research and discoveries in gastroenterology, and supports young investigators across the United States.

The AGA Research Foundation provides research grants to investigators in gastroenterology and hepatology.  The foundation's grants transform young researchers' lives by encouraging them to embark on and continue careers in research. Many ultimately make discoveries that improve patient care. Since 1984, the AGA has funded more than 700 scientists.

"We are proud to play a role in young investigators' ongoing research to better understand GI conditions and find innovative approaches to helping people," said Loren Laine , MD, AGAF, president of the AGA Institute. "Takeda's support of the AGA Research Foundation is a critical investment in the future of the field of gastroenterology that ensures we can continue funding research into the causes, diagnosis, prevention and treatment of digestive diseases." 

"For millions of Americans living with digestive disorders, ongoing research remains vital to expand our understanding of the conditions and hopefully improve outcomes. Generous contributions such as this one from Takeda Pharmaceuticals underscore that commitment," said David A. Peura , MD, AGAF, past president of the AGA. "With Takeda's help, we will be able to continue supporting young researchers and investigators across this therapeutic area."

About the AGA Research Foundation

The AGA Research Foundation is the foundation of the American Gastroenterological Asso
'/>"/>

SOURCE American Gastroenterological Association
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Army Researcher Develops Potential Vaccine Carrier That May Give Stockpiling Efforts A Shot In The Arm
2. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
3. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
4. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
5. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
6. Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate
7. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
8. ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report
9. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
10. ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report
11. Okuma America Chooses The Daniel Group To Provide Customer Service Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)...  ProteinSimple announced today that it has launched a ... allows users to detect all proteins separated in the ... can analyze proteins without the need for an antibody.  ... analysis as we know it today. First, the Simple Western ... messy gels, no transfer tanks, no blots, no imaging ...
(Date:7/28/2014)... and LONDON , July 28, 2014 ... to create and commercialize companion diagnostic using genomic data ...  for non-small cell lung cancer patients  New ... test and is planned to run on Rotor-Gene Q, member of ... enabled by AstraZeneca master framework agreement adds to QIAGEN,s ...
(Date:7/28/2014)... England , July 28, 2014 ... is investing £2.5 million to help it meet ... consumer goods, healthcare, pharmaceuticals and logistics. Albion joins ... ) Over the past 18 ... in its platform, its management team and its ...
Breaking Medicine Technology:ProteinSimple Says "Never Run a Gel Again!" 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6OmPrompt Funded for Customer Automation Management Market Expansion 2
... WOODLANDS, Texas, Dec. 5 Lexicon,Pharmaceuticals, Inc. (Nasdaq: ... in a Phase 2a clinical trial with LX6171, ... impairment associated with disorders such as,Alzheimer,s disease, schizophrenia, ... will assess the bioavailability of a new oral-suspension,formulation ...
... ulcerative colitis patients, AVENTURA, Fla., Dec. 5 ... that Asacol, an oral, non-steroidal medication that belongs,to ... (5-ASAs), is an,effective and well-tolerated treatment for patients ... proctitis. The results showed,that patients with isolated proctitis ...
Cached Medicine Technology:Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders 2Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders 3Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders 4Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis 2Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis 3Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis 4Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis 5
(Date:7/28/2014)... "We experienced difficulty filling our pill boxes ... inventors from Jamestown, Calif. "We came up with this ... could pour medications in more easily." , They created ... the lids open as the pill box is filled. ... have been filled. This eliminates hassles and frustrations, and ...
(Date:7/28/2014)... 2014 Scientists in Japan have completed ... blood test for the asbestos cancer mesothelioma. Surviving Mesothelioma ... Click here to read it now. , ... Juntendo University Graduate School of Medicine say a new ... step above the old test. , “Particularly for ...
(Date:7/28/2014)... 2014 The research found that most ... food best, with each subsequent bite being less satisfying ... actually serve to sabotage the meal. , "People ... not realizing the effect," Baba Shiv, the study's author, ... moderation, if we needed one. You actually take more ...
(Date:7/28/2014)... 2014 Labors.at, Austria’s largest and ... Healthcare Relationship Cloud™ to fuel its growth initiatives. ... to 8,000 patients daily and performs up to ... up to doubling its volume within the next ... cutting-edge 10,000 square meter facility pushed our team ...
(Date:7/28/2014)... information about the measles, mumps and rubella (MMR) vaccine ... new University of Leeds research has found. , Informing ... helping parents make a decision about MMR is on ... informing them solely via a GP consultation, and 7.17 ... vaccine. In each case, the figure comprises the cost ...
Breaking Medicine News(10 mins):Health News:Test Results Look Promising for New Mesothelioma Blood Test, According to Surviving Mesothelioma 2Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 2Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 3Health News:Austrian Laboratory Leader, Labors.at, Fuels Growth with the hc1® Healthcare Relationship Cloud™ 2Health News:Online information most cost-effective means of increasing MMR uptake, research finds 2
... (AMD) is the leading cause of severe visual loss ... common genetic variants which together predict a person,s increased ... without the disease also have these variants. Now, for ... show a specific rare mutation called CFH R1210C that ...
... Chapel Hill, NC In a study published today ... of scientists including UNC biologist Jason Lieb, PhD, present ... can survive with only one copy of the X ... topic in science and provides biologists with more information ...
... EAE President Doctor Luigi Badano, FESC, from the University ... we need to acquire information from all the different ... the ESC, the EAE,s philosophy is that we want ... oriented, so that we,re using the most appropriate technology ...
... Imagine having skin so supple you could stretch it out ... - repeatedly - yet it would always snap back completely ... never need Botox. That enviable elasticity is one of ... sensor that is the latest sensor developed by Stanford,s Zhenan ...
... 23 (HealthDay News) -- Gaining a significant amount of ... risk of developing endometrial cancer, a new study suggests. ... circulating estrogen in postmenopausal women, and estrogen promotes the ... of laboratory services at the National Home Office of ...
... Fla. October 24, 2011 A new analysis of recent eye ... to reduced rates of nearsightedness, also known as myopia, in ... the United States and many other countries than it was ... percent of the population is nearsighted. The analysis suggests that ...
Cached Medicine News:Health News:Researchers ID genetic mutation associated with high risk of age-related macular degeneration 2Health News:Study confirms males and females have at least 1 thing in common: Upregulating X 2Health News:Congress alert: EUROECHO and Other Imaging Modalities: New patient emphasis 2Health News:Congress alert: EUROECHO and Other Imaging Modalities: New patient emphasis 3Health News:Stanford researchers build transparent, super-stretchy skin-like sensor 2Health News:Stanford researchers build transparent, super-stretchy skin-like sensor 3Health News:Weight Gain Might Raise Endometrial Cancer Risk 2Health News:More time outdoors may reduce kids' risk for nearsightedness 2
Shahinian lachrymal cannula, blunt tapered with side port....
Shahinian lacrimal cannula, bullet shaped tip, 0.3 mm side opening, straight....
Button Tip Manipulator, 0.50 mm diameter button tip, angled 45 degrees, 15 mm from tip to bend....
Round serrated handle, polished finish, overall length 130 mm....
Medicine Products: